{"id":"W2424539745","doi":"10.1056/nejmoa1515920","title":"Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3629,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Empagliflozin; Medicine; Placebo; Hazard ratio; Internal medicine; Diabetes mellitus; Albuminuria; Renal function; Type 2 diabetes; Diabetic nephropathy; Creatinine; Kidney disease; Urology; Surgery; Confidence interval; Endocrinology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002161323,0.0002254256,0.0006815717,0.0003933198,0.0002018987,0.0004613723,0.00022508,0.0005102198,0.001431694],"category_scores_gemma":[0.003009828,0.0001031487,0.0004929211,0.0004610032,0.0002559322,0.000229461,0.0002859178,0.001041686,0.0001031515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004521426,"about_ca_system_score_gemma":0.0004967279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00164684,"about_ca_topic_score_gemma":0.001929335,"domain_scores_codex":[0.9991854,0.0004626879,0.00005935935,0.00006965225,0.0001760515,0.00004689647],"domain_scores_gemma":[0.998695,0.0005988672,0.0003738302,0.00003343563,0.000080276,0.0002186903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04164543,0.002642008,0.4187672,0.002217198,0.002221756,0.0008048023,0.000165391,0.002402229,0.001712585,0.001570226,0.01273601,0.5131151],"study_design_scores_gemma":[0.01114262,0.009425152,0.944227,0.0008309256,0.001738583,0.0019527,0.0000820983,0.004883373,0.0005917643,0.002799513,0.02228218,0.00004411815],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7898222,0.1908023,0.00154789,0.005331927,0.001078875,0.0001918496,0.0006527464,0.00005592186,0.0105163],"genre_scores_gemma":[0.9676468,0.02620971,0.001044912,0.001770652,0.001259801,0.0001150279,0.0004728581,0.000005806073,0.001474473],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002161323,"threshold_uncertainty_score":0.01143032,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01207844112599694,"score_gpt":0.278069689627907,"score_spread":0.2659912485019101,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}